0001181431-12-024892.txt : 20120419 0001181431-12-024892.hdr.sgml : 20120419 20120419183720 ACCESSION NUMBER: 0001181431-12-024892 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110601 FILED AS OF DATE: 20120419 DATE AS OF CHANGE: 20120419 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KUNG FRANK CENTRAL INDEX KEY: 0001227255 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35144 FILM NUMBER: 12769267 MAIL ADDRESS: STREET 1: C/O SAGENT PHARMACEUTICALS, INC. STREET 2: 1901 NORTH ROSELLE ROAD, SUITE 700 CITY: SCHAUMBURG, ILLINOIS 60195 STATE: IL ZIP: 60195 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sagent Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001369786 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 1901 NORTH ROSELLE ROAD, SUITE 700 CITY: SCHAUMBURG STATE: IL ZIP: 60195 BUSINESS PHONE: 847-908-1604 MAIL ADDRESS: STREET 1: 1901 NORTH ROSELLE ROAD, SUITE 700 CITY: SCHAUMBURG STATE: IL ZIP: 60195 FORMER COMPANY: FORMER CONFORMED NAME: Sagent Holding Co. DATE OF NAME CHANGE: 20090529 FORMER COMPANY: FORMER CONFORMED NAME: NHS PHARMACEUTICALS DATE OF NAME CHANGE: 20060720 4 1 rrd342153.xml X0305 4 2011-06-01 0 0001369786 Sagent Pharmaceuticals, Inc. SGNT 0001227255 KUNG FRANK C/O SAGENT PHARMACEUTICALS, INC. 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 1 0 0 0 Common Stock 2011-06-01 4 M 0 3190 4.23 A 29569 D Common Stock 8961452 I See Footnote Stock Option to Buy/Restricted Stock 4.23 2011-06-01 4 M 0 3190 0 D 2018-08-15 Common Stock 3190 3189 D Vesting of restricted stock resulting from early exercise of stock options. The shares reported are held of record collectively by Vivo Ventures Fund V, L.P., Vivo Ventures V Affiliates Fund, L.P., Vivo Ventures Fund VI, L.P. and Vivo Ventures VI Affiliates Fund, L.P. (the "Vivo Funds"). Dr. Kung is the managing partner of Vivo Ventures. As a result, Dr. Kung may be deemed the beneficial owner of the shares of common stock owned collectively by the Vivo Funds. Dr. Kung hereby disclaims any beneficial ownership of any shares directly held by the Vivo Funds, except to the extent of his pecuniary interest therein. Stock option granted on August 15, 2008 and vests 25% per year over four years. The 3,190 stock options reported had been early-exercised and were considered restricted stock. /s/ Frank Kung 2012-04-19